Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On January 5, 2026, CeriBell, Inc. (“Ceribell”) issued a press release announcing that the U.S. Food and Drug Administration (“FDA”) granted Break
Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated January 5, 2026. 104 Cover Page Interactive Data File, formatted in Inline X